Novonesis (Novozymes) B (NVZMF)
58.00
0.00 (0.00%)
USD |
OTCM |
Dec 16, 12:51
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 26.93B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | 12.05% |
Valuation | |
PE Ratio | -- |
PE Ratio (Forward) | Upgrade |
PS Ratio | -- |
Price to Book Value | 2.284 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 0.2983 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 0.5268 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 50.85% |
Profile
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark. |
URL | https://www.novozymes.com |
Investor Relations URL | https://investors.novozymes.com/ |
HQ State/Province | N/A |
Sector | Materials |
Industry | Chemicals |
Equity Style | Mid Cap/Growth |
Next Earnings Release | N/A |
Last Earnings Release | Nov. 07, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Aug. 29, 2024 |
Ratings
Profile
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark. |
URL | https://www.novozymes.com |
Investor Relations URL | https://investors.novozymes.com/ |
HQ State/Province | N/A |
Sector | Materials |
Industry | Chemicals |
Equity Style | Mid Cap/Growth |
Next Earnings Release | N/A |
Last Earnings Release | Nov. 07, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Aug. 29, 2024 |